Business News
-
As Claude Deals With Another Beat, Here’s Why HP and Intel Are the Most Underrated IT Stocks to Buy.
The arms race for productive artificial intelligence (AI) is entering a very disruptive phase, and the latest developments by Anthropic…
Read More » -
Warren Buffett once said that 2 investments would ‘increase’ his family’s wealth. How to follow
Moneywise and Yahoo Finance LLC may receive a commission or fee for linking to the content below. Warren Buffett is…
Read More » -
Warren Buffett said he would buy US stocks in the event of World War III – and warned against holding on to cash.
Moneywise and Yahoo Finance LLC may receive a commission or fee for linking to the content below. Geopolitical uncertainty rises…
Read More » -
Mortgage and refinance interest rates today, March 28, 2026:
Mortgage rates rose to their highest level in nearly six months. According to Zillow’s lender marketplace, the current 30-year fixed…
Read More » -
Only 1 of these 2 top REITs is Built to Pay You for Generations
With the war in the Middle East and oil prices rising, it seems chances are slim that the Fed will…
Read More » -
Get instant funding after approval
If you are short on cash and need it quickly, your choice of lenders may be limited. That can lead…
Read More » -
EnerSys Touts Data Center Growth, Lithium Trials and South Carolina Defense Pivot in Update Call
Enersys logo EnerSys holds approx 55% US market share in lead-acid data center batteries and expects that lead-acid business to…
Read More » -
BlackRock’s Larry Fink proposes reforming Social Security to diversify investments
The Big Money Show panel discusses new analysis that shows Social Security and Medicare are headed for bankruptcy and warns…
Read More » -
IRS ‘Where’s my refund?’ tool allows you to track your tax refund status online
Richard Bernstein Advisors CEO and CIO Richard Bernstein provides insight on investment strategies in a time of conflict and inflation…
Read More » -
J&J’s Darzalex nets the first self-administered injection permit
Johnson & Johnson’s (J&J) blockbuster cancer immunotherapy, Darzalex (daratumumab), has received European regulatory approval, marking the first time that an…
Read More »